16:43 EST Oncternal Therapeutics files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ONCT:
- Oncternal Therapeutics reports Q4 EPS ($3.11), consensus (3.07)
- Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
- Oncternal Therapeutics (ONCT) Q4 Earnings Cheat Sheet
- Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)